Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 13Breast Neoplasms 12Colorectal Neoplasms 11Colonic Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Carcinoma, Non-Small-Cell Lung 9Leukemia, Myeloid, Acute 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lung Neoplasms 7Kidney Neoplasms 7Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Gliosarcoma 6Glioblastoma 6Esophageal Neoplasms 6Congenital Abnormalities 6Stomach Neoplasms 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Lymphocytic, Chronic, B-Cell 5Central Nervous System Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Docetaxel 6Gemcitabine 3Carboplatin 3lorlatinib 2cemiplimab 2Vinorelbine 2S 1 (combination) 2Pemetrexed 2Erlotinib Hydrochloride 2Cisplatin 2Cetuximab 2zimberelimab 1surufatinib 1sintilimab 1quemliclustat 1pemigatinib 1pembrolizumab 1nimotuzumab 1fludarabine 1WW Domain-Containing Oxidoreductase 1Paclitaxel 1Interleukin-2 1Gene Expression Profiling 1Drug Therapy 1Cyclophosphamide 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Non-Small Cell Lung Cancer × Gene Expression Profiling × Clear all
NCT00161278 2008-07-30

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

University of Michigan Rogel Cancer Center

Phase 2 Terminated
1 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡